Avience Biomedicals IPO Allotment Chances

The allotment result is out. Chances below use the latest subscription figures, recorded 6:52 pm, 22 Jun IST.

The Avience Biomedicals allotment result is out — check whether you got shares. Check Avience Biomedicals allotment status

Avience Biomedicals IPO

Listed SME
Price Band
₹196–208
Minimum application
1,200 shares (2 lots)
Total Subscription
385.40x
Allotment date
23 Jun 2026
Allotment Chances — Avience Biomedicals IPO
Retail 0.28% (401.36x subscribed)
Low chance
S-HNI (₹2–10L) 0.22% (451.35x subscribed)
Low chance
B-HNI (>₹10L) 0.67% (670.77x subscribed)
Low chance
about 3 in 1,000 retail applicants are likely to get allotment.
Estimated from current subscription data, calibrated against published basis-of-allotment results. Actual allotment depends on the number of applications received and SEBI's allotment rules — draw of lots for Retail, Employee and NII; proportionate for QIB.
Applications vs Allotment Slots — Avience Biomedicals IPO

Avience Biomedicals reserved 4,81,200 shares for retail (individual) investors. Each winner gets 1,200 shares (2 lots), so there are 401 retail slots. Against 1,60,944 retail applications, that is about 2 in 1,000 applicants (0.25%).

CategoryApplicationsSubscriptionEst. chanceEst. allottees
Retail 1,60,944 401.36x 0.3% 457
S-HNI (₹2–10L) 15,344 451.35x 0.2% 34
B-HNI (>₹10L) 16,492 670.77x 0.7% 111
QIB 172 196.77x Proportionate —

Applications as reported at 6:52 pm, 22 Jun 2026 IST. B-HNI odds use a 4.50× correction from this issue's own lot value (₹1,24,800 per lot).

Avience Biomedicals Subscription, Day by Day
DayRetailNII QIB Total
Day 1 15.23x · 7.5% 13.43x 0.00x 10.51x
Day 2 58.02x · 2.0% 66.63x 0.03x 43.38x
Day 5 401.36x · 0.3% 597.63x 196.77x 385.40x

Times subscribed at the close of each bidding day; the % is the retail chance at that point.

Avience Biomedicals Allotment Chances FAQs

With retail subscribed 401.36x, about 0.3% of retail applicants (about 3 in 1,000) are likely to be allotted 1,200 shares (2 lots). S-HNI 451.35x, about 0.2%; B-HNI 670.77x, about 0.7%.

Avience Biomedicals reserved 4,81,200 shares for retail investors and each winner gets 1,200 shares (2 lots), so at most 401 retail applicants can be allotted. 1,60,944 retail applications had been received at the last update.

No. Oversubscribed retail and NII categories are allotted by draw of lots, and each retail winner receives the minimum application of 1,200 shares (2 lots) (₹2,49,600 at the upper price). Separate applications from family members, each with their own PAN, are what add entries to the draw.

The Avience Biomedicals allotment was finalised on 23 Jun 2026, with listing on 25 Jun 2026. Check the result with your PAN on the Avience Biomedicals allotment status page.

Avience Biomedicals IPO details · Avience Biomedicals allotment status · how allotment chances are worked out · chances for every open IPO

GMPUpdate